Business Wire India Worldwide revenue of $7.5 billion decreased 9% sequentially and 5% year-on-year International...
Business Wire India Worldwide revenue of $7.5 billion decreased 9% sequentially and 5% year-on-year International...
Business Wire IndiaSamsung Bioepis Co., Ltd. announced today that ONTRUZANT® (trastuzumab-dttb), a biosimilar of the...
Business Wire IndiaTransphorm Inc.— the leader in the design and manufacturing of the highest reliability...
Business Wire IndiaEUSA Pharma, a global biopharmaceutical company focused on oncology and rare disease, today...
Business Wire IndiaDhiway, India’s first Verifiable Data Exchange platform, is proud to announce that it has...
Business Wire IndiaNow developers can easily deploy their code across Limelight’s global edge platform with...
Business Wire India Simultaneous approval of VOCABRIA (cabotegravir oral tablets), for short-term treatment in conjunction...
Business Wire IndiaEUSA Pharma, a global biopharmaceutical company focused on oncology and rare disease, today...
Business Wire IndiaTakeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the Committee for Medicinal...
Business Wire IndiaA research team led by Dr. Yunching Chen and Tsai-Te Lu of National...